Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families

INTRODUCTION: Finding new immunohistochemical markers that are specific to hereditary breast cancer could help us to select candidates for BRCA1/BRCA2 mutation testing and to understand the biological pathways of tumour development. METHODS: Using breast cancer tumour microarrays, immunohistochemica...

Descripción completa

Detalles Bibliográficos
Autores principales: Eerola, Hannaleena, Heinonen, Mira, Heikkilä, Päivi, Kilpivaara, Outi, Tamminen, Anitta, Aittomäki, Kristiina, Blomqvist, Carl, Ristimäki, Ari, Nevanlinna, Heli
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374973/
https://www.ncbi.nlm.nih.gov/pubmed/18275599
http://dx.doi.org/10.1186/bcr1863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374973/
https://www.ncbi.nlm.nih.gov/pubmed/18275599
http://dx.doi.org/10.1186/bcr1863

Ejemplares similares